首页 > 最新文献

Best Practice & Research Clinical Gastroenterology最新文献

英文 中文
The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis 微生物组在免疫检查点抑制剂结肠炎和肝炎中的作用
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-21 DOI: 10.1016/j.bpg.2024.101945
Thomas Ryan, Sophia Ling, Andrew Trinh, Jonathan P. Segal
Immune checkpoint inhibitors have revolutionised management for a variety of different types of malignancies. However, gastrointestinal adverse effects, in particular colitis and hepatitis, are relatively common with up to 30 % of patients being affected. The gut microbiome has emerged as a potential contributor to both the effectiveness of immune checkpoint inhibitors and their side effects. This review will attempt to examine the impact the microbiome has on adverse effects as a result of immune checkpoint inhibitors as well as the potential for manipulation of the microbiome as a form of management for immune mediated colitis.
免疫检查点抑制剂彻底改变了对各种不同类型恶性肿瘤的治疗。然而,胃肠道不良反应,尤其是结肠炎和肝炎相对常见,多达 30% 的患者受到影响。肠道微生物组已成为影响免疫检查点抑制剂疗效及其副作用的潜在因素。本综述将尝试研究微生物组对免疫检查点抑制剂不良反应的影响,以及操纵微生物组作为治疗免疫介导的结肠炎的一种形式的潜力。
{"title":"The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis","authors":"Thomas Ryan, Sophia Ling, Andrew Trinh, Jonathan P. Segal","doi":"10.1016/j.bpg.2024.101945","DOIUrl":"https://doi.org/10.1016/j.bpg.2024.101945","url":null,"abstract":"Immune checkpoint inhibitors have revolutionised management for a variety of different types of malignancies. However, gastrointestinal adverse effects, in particular colitis and hepatitis, are relatively common with up to 30 % of patients being affected. The gut microbiome has emerged as a potential contributor to both the effectiveness of immune checkpoint inhibitors and their side effects. This review will attempt to examine the impact the microbiome has on adverse effects as a result of immune checkpoint inhibitors as well as the potential for manipulation of the microbiome as a form of management for immune mediated colitis.","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"43 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142186346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy 肠道微生物组在调节免疫检查点抑制剂疗法反应中的作用
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-13 DOI: 10.1016/j.bpg.2024.101944
Nathan J. Dean, Paolo D. d’Arienzo, Hajir Ibraheim, Karla A. Lee, Anna C. Olsson-Brown, David J. Pinato, Nicholas Powell
Immune checkpoint inhibitors (ICIs) have revolutionised cancer therapy, yet the proportion of patients who achieve long-term disease control remain suboptimal. Over the past decade, the gut microbiome has been shown to influence immune-mediated tumour suppression as well as responses to ICI therapies. Compositional differences in gut microbiome may account for the differences in outcomes from immune checkpoint blockade. Identifying microbiota species associated with favourable/unfavourable outcomes and modelling their dynamics throughout the course of ICI treatment could help develop predictive biomarkers of immunotherapy response, and manipulating the gut microbiome represent a novel approach to enhancing ICI effectiveness. Clinically, this raises the prospect of using gut microbiome-based therapies to overcome primary resistance to ICIs, mitigate the effects of microbiome-altering drugs such as antibiotics or proton pump inhibitors, and improve overall survival in patients across numerous different cancer types.
免疫检查点抑制剂(ICIs)给癌症治疗带来了革命性的变化,但实现长期疾病控制的患者比例仍不理想。在过去十年中,肠道微生物组已被证明会影响免疫介导的肿瘤抑制以及对 ICI 疗法的反应。肠道微生物组的组成差异可能是免疫检查点阻断治疗结果差异的原因。确定与有利/不利结果相关的微生物群种类并模拟它们在 ICI 治疗过程中的动态变化,有助于开发免疫疗法反应的预测性生物标志物,操纵肠道微生物群是提高 ICI 效果的一种新方法。在临床上,这为利用基于肠道微生物组的疗法克服对 ICIs 的原发性耐药性、减轻抗生素或质子泵抑制剂等改变微生物组的药物的影响以及提高多种不同癌症类型患者的总体生存率带来了前景。
{"title":"The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy","authors":"Nathan J. Dean, Paolo D. d’Arienzo, Hajir Ibraheim, Karla A. Lee, Anna C. Olsson-Brown, David J. Pinato, Nicholas Powell","doi":"10.1016/j.bpg.2024.101944","DOIUrl":"https://doi.org/10.1016/j.bpg.2024.101944","url":null,"abstract":"Immune checkpoint inhibitors (ICIs) have revolutionised cancer therapy, yet the proportion of patients who achieve long-term disease control remain suboptimal. Over the past decade, the gut microbiome has been shown to influence immune-mediated tumour suppression as well as responses to ICI therapies. Compositional differences in gut microbiome may account for the differences in outcomes from immune checkpoint blockade. Identifying microbiota species associated with favourable/unfavourable outcomes and modelling their dynamics throughout the course of ICI treatment could help develop predictive biomarkers of immunotherapy response, and manipulating the gut microbiome represent a novel approach to enhancing ICI effectiveness. Clinically, this raises the prospect of using gut microbiome-based therapies to overcome primary resistance to ICIs, mitigate the effects of microbiome-altering drugs such as antibiotics or proton pump inhibitors, and improve overall survival in patients across numerous different cancer types.","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"67 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142186347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut microbiota in colorectal cancer: From pathogenesis to clinic 大肠癌中的肠道微生物群:从发病机制到临床
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-03 DOI: 10.1016/j.bpg.2024.101941
William Fusco, Ludovica Bricca, Francesco Kaitsas, Maria Francesca Tartaglia, Irene Venturini, Massimo Rugge, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro
Colorectal cancer is the third most common type of cancer, with a significant burden on healthcare and social systems. Its incidence is constantly rising, due to the spread of unhealthy lifestyle, i.e. Western diet. Increasing evidence suggests that westernization-driven microbiome alterations may play a critical role in colorectal tumorigenesis. The current screening strategies for this neoplasm, mainly fecal immunochemical tests, are burdened by unsatisfactory accuracy. Novel, non-invasive biomarkers are rising as the new frontier of colorectal cancer screening, and the microbiome-based ones are showing positive and optimistic results. This Review describes our current knowledge on the role of gut microbiota in colorectal cancer, from its pathogenetic action to its clinical potential as diagnostic biomarker.
结肠直肠癌是第三大常见癌症,给医疗保健和社会系统带来沉重负担。由于不健康生活方式(即西方饮食习惯)的蔓延,其发病率不断上升。越来越多的证据表明,西方化驱动的微生物组改变可能在结直肠肿瘤发生过程中起到关键作用。目前针对这种肿瘤的筛查策略主要是粪便免疫化学检测,其准确性并不令人满意。新型非侵入性生物标志物正成为结直肠癌筛查的新领域,而基于微生物组的生物标志物正显示出积极乐观的结果。本综述介绍了我们目前对肠道微生物群在结直肠癌中作用的认识,包括其致病作用及其作为诊断生物标志物的临床潜力。
{"title":"Gut microbiota in colorectal cancer: From pathogenesis to clinic","authors":"William Fusco, Ludovica Bricca, Francesco Kaitsas, Maria Francesca Tartaglia, Irene Venturini, Massimo Rugge, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro","doi":"10.1016/j.bpg.2024.101941","DOIUrl":"https://doi.org/10.1016/j.bpg.2024.101941","url":null,"abstract":"Colorectal cancer is the third most common type of cancer, with a significant burden on healthcare and social systems. Its incidence is constantly rising, due to the spread of unhealthy lifestyle, i.e. Western diet. Increasing evidence suggests that westernization-driven microbiome alterations may play a critical role in colorectal tumorigenesis. The current screening strategies for this neoplasm, mainly fecal immunochemical tests, are burdened by unsatisfactory accuracy. Novel, non-invasive biomarkers are rising as the new frontier of colorectal cancer screening, and the microbiome-based ones are showing positive and optimistic results. This Review describes our current knowledge on the role of gut microbiota in colorectal cancer, from its pathogenetic action to its clinical potential as diagnostic biomarker.","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"3 1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141945574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Per oral endoscopic myotomy for achalasia 治疗贲门失弛缓症的经口腔内窥镜肌切开术
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.bpg.2024.101930

Achalasia, characterized by impaired lower esophageal sphincter (LES) relaxation and failed peristalsis, stands out as the most widely recognized primary esophageal motility disorder. It manifests with dysphagia to solid and liquid foods, chest pain, regurgitation, and weight loss, leading to significant morbidity and healthcare burden. Traditionally, surgical Heller myotomy and pneumatic dilation were the primary therapeutic approaches for achalasia. However, in 2009, Inoue and colleagues introduced a groundbreaking endoscopic technique called peroral endoscopic myotomy (POEM), revolutionizing the management of this condition. This review aims to comprehensively examine the recent advancements in the POEM technique for patients diagnosed with achalasia, delving into critical aspects, such as the tailoring of the myotomy, the prevention of intraprocedural adverse events (AEs), the evaluation of long-term outcomes, and the feasibility of retreatment in cases of therapeutic failure.

以食管下括约肌(LES)松弛功能受损和蠕动功能障碍为特征的食管失弛缓症是公认的最常见的原发性食管运动障碍。它表现为吞咽固体和液体食物困难、胸痛、反流和体重减轻,导致严重的发病率和医疗负担。传统上,手术海勒肌切开术和气压扩张术是治疗贲门失弛缓症的主要方法。然而,2009 年,Inoue 及其同事推出了一种开创性的内窥镜技术--口周内窥镜肌切开术 (POEM),彻底改变了这种疾病的治疗方法。本综述旨在全面探讨针对贲门失弛缓症患者的口内镜肌切开术(POEM)的最新进展,深入探讨肌切开术的定制、术中不良事件(AEs)的预防、长期疗效评估以及治疗失败情况下再治疗的可行性等关键问题。
{"title":"Per oral endoscopic myotomy for achalasia","authors":"","doi":"10.1016/j.bpg.2024.101930","DOIUrl":"10.1016/j.bpg.2024.101930","url":null,"abstract":"<div><p><span><span><span>Achalasia, characterized by impaired lower esophageal sphincter (LES) relaxation and failed </span>peristalsis<span>, stands out as the most widely recognized primary esophageal motility disorder. It manifests with </span></span>dysphagia<span> to solid and liquid foods, chest pain<span>, regurgitation, and weight loss, leading to significant morbidity and healthcare burden. Traditionally, surgical Heller myotomy<span> and pneumatic dilation were the primary therapeutic approaches for achalasia. However, in 2009, Inoue and colleagues introduced a groundbreaking endoscopic technique called peroral endoscopic myotomy (POEM), revolutionizing the management of this condition. This review aims to comprehensively examine the recent advancements in the POEM technique for patients diagnosed with achalasia, delving into critical aspects, such as the tailoring of the myotomy, the prevention of intraprocedural adverse events (AEs), the evaluation of long-term outcomes, and the feasibility of </span></span></span></span>retreatment in cases of therapeutic failure.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"71 ","pages":"Article 101930"},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141395233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perface to special edition: Third space endoscopy 特刊序言:第三空间内窥镜
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.bpg.2024.101940
Jan Martinek
{"title":"Perface to special edition: Third space endoscopy","authors":"Jan Martinek","doi":"10.1016/j.bpg.2024.101940","DOIUrl":"10.1016/j.bpg.2024.101940","url":null,"abstract":"","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"71 ","pages":"Article 101940"},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141785964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic pyloromyotomy for treatment of gastroparesis: A new standard or still an experimental approach? 内镜幽门切开术治疗胃瘫:新标准还是试验性方法?
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.bpg.2024.101910

Gastroparesis (GP) can be a severe and debilitating disease. Its pathophysiology is complex and not completely understood. Two principal mechanisms are responsible for the development of symptoms – gastric hypomotility and pylorospasm. Pylorus targeted therapies aim to decrease presumably elevated pyloric tone – pylorospasm. There is a growing body of evidence about their role in the treatment algorithm of GP. G-POEM (endoscopic pyloromyotomy) is an extensively studied pylorus targeted therapy. Its efficacy ranges between 56 and 80% and the number of recurrences among those with treatment effect seems low. G-POEM is a safe procedure with very low frequency of severe adverse events. At present, G-POEM should not be considered as an experimental approach and may be offered to all patients with refractory and severe GP. Nevertheless, G-POEM is not a first line treatment. Conservative measures such as diet modification and pharmacotherapy should always be tried before G-POEM is considered. Further research must focus on better patient selection as at present there are no standardized criteria. Functional imaging such as impedance planimetry (EndoFlip) may hold promise in this regard.

胃痉挛(GP)是一种严重的衰弱性疾病。其病理生理学十分复杂,尚未完全明了。导致症状出现的主要机制有两个--胃运动减弱和幽门痉挛。幽门靶向疗法旨在降低推测的幽门张力升高--幽门痉挛。越来越多的证据表明,幽门靶向疗法在 GP 的治疗方案中发挥着重要作用。G-POEM(内镜幽门肌切开术)是一种经过广泛研究的幽门靶向疗法。其疗效介于 56% 和 80% 之间,有疗效者的复发率似乎很低。G-POEM 是一种安全的手术,发生严重不良反应的频率很低。目前,G-POEM 不应被视为一种试验性方法,所有难治性和严重 GP 患者均可采用。然而,G-POEM 并非一线治疗方法。在考虑使用 G-POEM 之前,应先行尝试饮食调整和药物治疗等保守疗法。由于目前还没有统一的标准,进一步的研究必须侧重于更好地选择患者。在这方面,阻抗平面测量法(EndoFlip)等功能成像技术可能大有可为。
{"title":"Endoscopic pyloromyotomy for treatment of gastroparesis: A new standard or still an experimental approach?","authors":"","doi":"10.1016/j.bpg.2024.101910","DOIUrl":"10.1016/j.bpg.2024.101910","url":null,"abstract":"<div><p><span>Gastroparesis (GP) can be a severe and debilitating disease. Its </span>pathophysiology<span> is complex and not completely understood. Two principal mechanisms are responsible for the development of symptoms – gastric hypomotility and pylorospasm. Pylorus<span><span> targeted therapies aim to decrease presumably elevated pyloric tone – pylorospasm. There is a growing body of evidence about their role in the treatment algorithm of GP. G-POEM (endoscopic pyloromyotomy) is an extensively studied pylorus targeted therapy. Its efficacy ranges between 56 and 80% and the number of recurrences among those with treatment effect seems low. G-POEM is a safe procedure with very low frequency of severe </span>adverse events<span>. At present, G-POEM should not be considered as an experimental approach and may be offered to all patients with refractory and severe GP. Nevertheless, G-POEM is not a first line treatment. Conservative measures such as diet modification and pharmacotherapy should always be tried before G-POEM is considered. Further research must focus on better patient selection as at present there are no standardized criteria. Functional imaging such as impedance planimetry (EndoFlip) may hold promise in this regard.</span></span></span></p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"71 ","pages":"Article 101910"},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140585091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging indications for third space endoscopy 第三空间内窥镜检查的新适应症
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.bpg.2024.101911

This chapter will explore the recent advancements and innovations in the field of third space endoscopy. The traditional principles of per-oral endoscopic myotomy and endoscopic submucosal dissection have been applied to offer solutions to traditionally difficult to manage problems including esophageal diverticula, post-fundoplication dysphagia, post-sleeve gastrectomy stricture, bariatric procedure and Hirschsprung disease. Typically, these problems were managed surgically with potentially high rates of morbidity and mortality; however, the principles of third space endoscopy offer a safer and less invasive option for management. All of these applications of third space endoscopy are less than a decade old with some emerging in the last 1–2 years. In this chapter, we will explore the pathophysiology of these diseases and how third space endoscopy can offer a solution. We will also review the relevant literature along with the safety and effectiveness of the proposed innovations.

本章将探讨第三空间内窥镜领域的最新进展和创新。传统的经口内镜下肌切开术和内镜下粘膜下剥离术的原理已被用于解决传统上难以处理的问题,包括食管憩室、基金折叠术后吞咽困难、袖状胃切除术后狭窄、减肥手术和赫氏胃病。通常情况下,这些问题都是通过手术来解决的,其发病率和死亡率可能很高;然而,第三空间内窥镜检查的原理提供了一种更安全、创伤更小的治疗方法。所有这些第三空间内窥镜应用的历史都不到十年,其中一些是在最近 1-2 年内出现的。在本章中,我们将探讨这些疾病的病理生理学以及第三空间内窥镜如何提供解决方案。我们还将回顾相关文献,以及拟议创新的安全性和有效性。
{"title":"Emerging indications for third space endoscopy","authors":"","doi":"10.1016/j.bpg.2024.101911","DOIUrl":"10.1016/j.bpg.2024.101911","url":null,"abstract":"<div><p><span>This chapter will explore the recent advancements and innovations in the field of third space endoscopy. The traditional principles of per-oral endoscopic myotomy and </span>endoscopic submucosal dissection<span> have been applied to offer solutions to traditionally difficult to manage problems including esophageal diverticula<span>, post-fundoplication dysphagia<span>, post-sleeve gastrectomy stricture, bariatric procedure<span> and Hirschsprung disease<span>. Typically, these problems were managed surgically with potentially high rates of morbidity and mortality; however, the principles of third space endoscopy offer a safer and less invasive option for management. All of these applications of third space endoscopy are less than a decade old with some emerging in the last 1–2 years. In this chapter, we will explore the pathophysiology of these diseases and how third space endoscopy can offer a solution. We will also review the relevant literature along with the safety and effectiveness of the proposed innovations.</span></span></span></span></span></p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"71 ","pages":"Article 101911"},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140806361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to close mucosal incisions? 如何缝合粘膜切口?
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.bpg.2024.101938
Rastislav Hustak

This article provides an overview of the techniques for closure of the mucosal entry point following advanced procedures in the third space. The outbreak of natural orifice transluminal endoscopic surgery (NOTES) has significantly impacted the treatment of various benign and malignant conditions. Reliable and secure closure of the mucosal entrance is essential for avoiding serious adverse events.

Although small defects are typically closed using through-the-scope clips (TTSCs) or over-the-scope clips (OTSCs), challenges may occur with larger or transmural defects. Alternative methods, such as specialised stitches and full-thickness suturing systems, have been developed to address these challenges with promising results. Each method has its own pros and cons, and the choice of closure technique depends on various factors such as anatomical location, endoscopist expertise, costs, and clinical context.

By understanding the technical specifications of each closure device, endoscopists can make decisions that enhance patient outcomes and minimise the risk of complications associated with the approximation of defect edges. Continued research is essential to optimise the evolution of newer closure devices and techniques for advancing NOTES.

本文概述了在第三空间进行高级手术后关闭粘膜入口点的技术。自然腔道内镜手术(NOTES)的爆发对各种良性和恶性疾病的治疗产生了重大影响。要避免严重不良事件的发生,可靠、安全地关闭粘膜入口至关重要。虽然小的缺损通常使用镜内夹或镜外夹关闭,但较大或跨壁缺损可能会遇到困难。为了应对这些挑战,人们开发了其他方法,如专用缝合线和全厚缝合系统,并取得了可喜的成果。每种方法都有其利弊,选择哪种闭合技术取决于解剖位置、内镜医师的专业知识、成本和临床环境等各种因素。通过了解每种闭合设备的技术规格,内镜医师可以做出提高患者治疗效果的决定,并最大限度地降低与接近缺损边缘相关的并发症风险。持续的研究对于优化更新的闭合设备和技术以推进 NOTES 的发展至关重要。
{"title":"How to close mucosal incisions?","authors":"Rastislav Hustak","doi":"10.1016/j.bpg.2024.101938","DOIUrl":"10.1016/j.bpg.2024.101938","url":null,"abstract":"<div><p>This article provides an overview of the techniques for closure of the mucosal entry point following advanced procedures in the third space. The outbreak of natural orifice transluminal endoscopic surgery (NOTES) has significantly impacted the treatment of various benign and malignant conditions. Reliable and secure closure of the mucosal entrance is essential for avoiding serious adverse events.</p><p>Although small defects are typically closed using through-the-scope clips (TTSCs) or over-the-scope clips (OTSCs), challenges may occur with larger or transmural defects. Alternative methods, such as specialised stitches and full-thickness suturing systems, have been developed to address these challenges with promising results. Each method has its own pros and cons, and the choice of closure technique depends on various factors such as anatomical location, endoscopist expertise, costs, and clinical context.</p><p>By understanding the technical specifications of each closure device, endoscopists can make decisions that enhance patient outcomes and minimise the risk of complications associated with the approximation of defect edges. Continued research is essential to optimise the evolution of newer closure devices and techniques for advancing NOTES.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"71 ","pages":"Article 101938"},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141704189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating the learning landscape: Comprehensive training in third space endoscopy - training, techniques, and practical recommendations 学习导航:第三空间内窥镜培训、技术和实用建议的综合培训
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.bpg.2024.101918

Third space endoscopy (TSE), including ESD, POEM, or STER are advanced procedures requiring precise endoscopic control and tissue recognition. Despite its increasing adoption, evidence-based curricula, and standardized training protocols for TSE are lacking. This review explores training methods, cognitive skills, and technical proficiency requirements for endoscopists performing TSE, with a primary emphasis on POEM. Generally, it seems wise to recommend a step-up approach to TSE training, starting with ex-vivo models or POEM simulators; mechanical and virtual reality (VR) simulators are commonly used during early training. Preclinical training involving ex-vivo and live animal models is suggested to prepare trainees for safe and effective procedures. Studies suggest varying numbers of procedures for training, with approximately 20–40 cases needed before a first plateau is achieved in terms of complications and speed. The duration of on-patient clinical training varies depending on prior experience. Mentorship programs, workshops, and case discussions may facilitate dynamic knowledge transfer. In addition, adverse event management is a crucial aspect of any TSE training program. Existing evidence supports the use of preclinical models and emphasizes the importance of specialized training programs for TSE in alignment with our proposed step-up training approach. This review outlines practical recommendations for the theoretical knowledge and technical skills required before commencing TSE training, covering clinical understanding, diagnostic and outcome assessment, procedural requirements, and the role of mentorship programs.

第三空间内窥镜检查(TSE),包括ESD、POEM或STER,都是需要精确内窥镜控制和组织识别的高级手术。尽管 TSE 的应用越来越广泛,但目前还缺乏循证课程和标准化培训方案。本综述探讨了内镜医师执行 TSE 的培训方法、认知技能和技术熟练程度要求,重点是 POEM。一般来说,建议采用循序渐进的方法进行 TSE 培训似乎是明智之举,首先从体内外模型或 POEM 模拟器开始;机械和虚拟现实 (VR) 模拟器通常用于早期培训。建议进行涉及体外和活体动物模型的临床前培训,使学员为安全有效的手术做好准备。研究表明,培训的手术数量不尽相同,大约需要 20-40 个病例才能在并发症和速度方面达到第一个高峰。住院临床培训的时间长短取决于先前的经验。导师计划、研讨会和病例讨论可促进知识的动态传递。此外,不良事件处理也是任何 TSE 培训计划的一个重要方面。现有证据支持使用临床前模型,并强调了与我们所建议的阶梯式培训方法一致的 TSE 专业培训计划的重要性。本综述概述了开始 TSE 培训前所需理论知识和技术技能的实用建议,包括临床理解、诊断和结果评估、程序要求以及导师计划的作用。
{"title":"Navigating the learning landscape: Comprehensive training in third space endoscopy - training, techniques, and practical recommendations","authors":"","doi":"10.1016/j.bpg.2024.101918","DOIUrl":"10.1016/j.bpg.2024.101918","url":null,"abstract":"<div><p>Third space endoscopy (TSE), including ESD, POEM, or STER are advanced procedures requiring precise endoscopic control and tissue recognition. Despite its increasing adoption, evidence-based curricula, and standardized training protocols for TSE are lacking. This review explores training methods, cognitive skills, and technical proficiency requirements for endoscopists performing TSE, with a primary emphasis on POEM. Generally, it seems wise to recommend a step-up approach to TSE training, starting with ex-vivo models or POEM simulators; mechanical and virtual reality (VR) simulators are commonly used during early training. Preclinical training involving ex-vivo and live animal models is suggested to prepare trainees for safe and effective procedures. Studies suggest varying numbers of procedures for training, with approximately 20–40 cases needed before a first plateau is achieved in terms of complications and speed. The duration of on-patient clinical training varies depending on prior experience. Mentorship programs, workshops, and case discussions may facilitate dynamic knowledge transfer. In addition, adverse event management is a crucial aspect of any TSE training program. Existing evidence supports the use of preclinical models and emphasizes the importance of specialized training programs for TSE in alignment with our proposed step-up training approach. This review outlines practical recommendations for the theoretical knowledge and technical skills required before commencing TSE training, covering clinical understanding, diagnostic and outcome assessment, procedural requirements, and the role of mentorship programs.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"71 ","pages":"Article 101918"},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1521691824000404/pdfft?md5=2973dab4291362866783e9ff021359d7&pid=1-s2.0-S1521691824000404-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141057091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic removal of gastrointestinal lesions by using third space endoscopy techniques 利用第三空间内窥镜技术在内窥镜下切除胃肠道病灶
IF 3.2 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.bpg.2024.101931

The concept of submucosal space, or rather the “third space”, located between the intact mucosal flap and the muscularis propria layer of the gastrointestinal tract, represents a tunnel that the endoscopist could use to perform interventions in the muscularis propria layer or breech it to enter the mediastinum or the peritoneal cavity without full thickness perforation.

The tunnel technique can be used both for the removal of mucosal tumours, called endoscopic submucosal tunnel dissection (ESTD), for the removal of subepithelial tumours (SELs), called submucosal tunnelling endoscopic resection (STER), and for the removal of extra-luminal lesions (for example in the mediastinum or in the rectum), called submucosal tunnelling endoscopic resection for extraluminal tumours (STER-ET).

Aim of this updated narrative review, is to summarize the evidences that analyses indications, and outcomes of tunnelling techniques for the treatment of above mentioned lesions.

位于胃肠道完整粘膜瓣和固有肌层之间的粘膜下间隙,或者说 "第三间隙 "的概念,代表了内镜医师可以用来对固有肌层进行干预,或者在不进行全层穿孔的情况下穿透粘膜下间隙进入纵隔或腹腔的通道。
{"title":"Endoscopic removal of gastrointestinal lesions by using third space endoscopy techniques","authors":"","doi":"10.1016/j.bpg.2024.101931","DOIUrl":"10.1016/j.bpg.2024.101931","url":null,"abstract":"<div><p><span>The concept of submucosal space, or rather the “third space”, located between the intact mucosal flap and the muscularis propria layer of the gastrointestinal tract, represents a tunnel that the endoscopist could use to perform interventions in the muscularis propria layer or breech it to enter the mediastinum or the </span>peritoneal cavity without full thickness perforation.</p><p>The tunnel technique can be used <del>both</del><span> for the removal of mucosal tumours, called endoscopic submucosal tunnel dissection (ESTD), for the removal of subepithelial tumours (SELs), called submucosal tunnelling endoscopic resection (STER), and for the removal of extra-luminal lesions (for example in the mediastinum or in the rectum), called submucosal tunnelling endoscopic resection for extraluminal tumours (STER-ET).</span></p><p>Aim of this updated narrative review, is to summarize the evidences that analyses indications, and outcomes of tunnelling techniques for the treatment of above mentioned lesions.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"71 ","pages":"Article 101931"},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141502795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Best Practice & Research Clinical Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1